MPM BioImpact’s Arcturus Therapeutics ARCT Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-459,943	Closed	-$7.81M	–	46
2024 Q4	$7.81M	Buy	459,943 +240,435	+110%	+$4.08M	1.11%	35
2024 Q3	$5.09M	Buy	+219,508	New	+$5.09M	0.76%	36